Biotech & MedTech
-
Driving to deliver on their 800M mask coatings per month demand, ZEN Graphene up 746% over the past year
ZEN Graphene Solutions Ltd. (TSXV: ZEN) (‘ZEN’) continues to move at a rapid pace with demand for their…
-
A ‘catch and kill’ mask that offers to get us back to work, welcome SINTX
A classic story of repurposing your tried and true Intellectual Property, allow me to introduce you to SINTX…
-
XPhyto Therapeutics is looking to hit a home run with their innovative medical products and therapies
New therapies and diagnostics in the pharmaceutical and medical industries can be a very lucrative area. To be…
-
XPhyto Therapeutics Hugh Rogers on the fastest and most portable PCR test available
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.…
-
Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology
CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is…
-
Warrant Exercise Builds Treasury for Perimeter’s 2021 Commercialization Efforts
Last week, Perimeter Medical Imaging AI, Inc. (TSXV: PINK) announced that approximately 2.35 million warrants subject to an…
-
Revenue is forecast to triple, Valeo Pharma has 10 products in their portfolio
COVID-19 continues to be a huge global problem with global cases now over 112 million. Vaccines are a…
-
Valeo Pharma’s Steve Saviuk on Hesperidin and reducing the risk of securing COVID-19
In a new InvestorIntel interview Tracy Weslosky speaks with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH…
-
Fully funded with strong IP Portfolio, Hemostemix marches forward towards FDA Phase II Clinical Trial Completion
Hemostemix Inc. (TSXV: HEM | OTC: HMTXF) continues to move forward with its FDA Phase II clinical trial…
-
Sixth Wave’s Dr Jon Gluckman on the First Polymer for Detection of SARS-CoV-2
In a recent InvestorIntel interview, Peter Clausi speaks with Dr. Jon Gluckman, President, CEO and Founder of Sixth Wave…